Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
ACTH
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
aerobic exercise
alemtuzumab
algorithm
alkylating agents
alopecia
alternative medicine
amantadine
amenorrhea
aminopyridine, 4
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, treatment of
anaphylaxis
anemia
anesthesia, epidural
anesthesia, spinal
anti JC virus antibodies
antihistamines
antineutrophil cytoplasmic autoantibodies
antisense therapy
antispasticity drugs
anxiety
arachnoiditis
arrhythmia, cardiac
asymptomatic
atorvastatin
audiogram
auditory and vestibular pathways
autoimmune disease
axonal degeneration
azathioprine
B cell lymphocyte depletion
B cell lymphocytes
baclofen
bacterial infection
bacterial infection, CNS
Barkhof MR criteria for MS
BENEFIT study
biologic markers
black box warning
bladder dysfunction
blood brain barrier
bone marrow suppression
bone marrow transplantation
botulinum toxin
bradycardia
bradykinesia
brain atrophy
brain biopsy
brain biopsy, false negative
brain biopsy, indication
brain biopsy, negative
brain volume
breast feeding
BTK inhibitors
candida albicans
carbamazepine
carcinoma
carcinoma of breast
cardiomyopathy
cardiotoxicity
CAT scan, chest
central nervous system, infection of
cerebral cortical atrophy
cerebral hypersensitivity, delayed
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
children
chills
cholecystitis
cladribine
clemastine fumarate
Clinical Pathologic Conference(C.P.C.)
clonus
cognition
coinfection
complementary medicine
compliance
complications
conduction block
confusion
congestive heart failure
contrast sensitivity
controversies in neurology
cooling therapy
cop 1
cost
cost effectiveness
cotton-wool spots
cranial neuropathy
cranial neuropathy, multiple
cryptococcal meningitis
cyclophosphamide
cyclosporine
cytokines
cytomegalovirus infection
daclizumab
dantrolene sodium
degenerative diseases of CNS
delay in diagnosis
demyelinating disease
depression
dermatomyositis
dexamethasone suppression test
diagnostic criteria
diaminopyridine, 3, 4
diet
dietary supplement
differential diagnosis
digitalis
dilantin
disability rating scale, neurological
disability, neurological
disease modifying agents
dizziness
dorsal column stimulator
droperidol
drowsiness
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dura, thickened
dysgeusia
echocardiogram
efficacy
ejection fraction
ejection fraction, abnormal
electrocardiogram, abnormal
emotional lability
empyema, epidural
encephalitis, viral
eosinophilia
epidemiology of neurology
epidural steroid
Epstein-Barr virus
Epstein-Barr virus, negative
ethics in neurology
EVIDENCE trial
evidence-based research
evoked potentials
exercise
exercise-induced vascular symptoms
facial weakness
fasciculation
fatigue
fetus
fever
fingolimod
fingolimod, discontinuation
flexor spasm
flicker fusion test
flu-like illness
frexalimab
fumarate
fundus, abnormality of
gadolinium
gag reflex, depressed
gait disorder
gamma amino butyric acid-mimetic drug
gammaglobulin therapy, intravenous
genetic neurologic disorders
granulomatosis with polyangiitis
grasp reflex
gray matter
guanidine
Guillain Barre syndrome
headache
hearing loss
hemophagocytic lymphohistiocytosis
hepatic failure
herniated disc, steroid treatment of
herpes simplex encephalitis
herpes simplex virus
herpes virus
herpes virus infection
herpes zoster
herpes zoster, disseminated
herpes zoster, ophthalmicus
HLA
hot bath test
human herpesvirus 6
hydrocephalus
hydrocephalus, exvacuo
hyperbaric oxygen
hyperbaric treatment
hyperhidrosis
hypersensitivity reaction
hypertension
hyperthermia
hypothermia
iatrogenic neurologic disorders
ibuprofen
idiopathic thrombocytopenic purpura
immune reconstitution inflammatory syndrome
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion body myositis
infection
infliximab
infusion pump
infusion-associated reaction
interferon
interferon alpha
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon gamma
interferon, intrathecal
interleukin 2
interleukin 6
internet
interobserver agreement
intrathecal antispasticity drugs
intrathecal steroid
intrauterine
intravenous
iron, serum, elevated
Isaacs syndrome
isoniazid
JC virus
laquinimod
leukemia
leukopenia
limbic encephalitis
linomide
listeria monocytogenes
liver disease
liver function enzymes
lymphadenopathy
lymphoma
lymphoma, primary of CNS
lymphopenia
macular edema
mannitol
marihuana
McDonald criteria for MS
meclizine
medication withdrawal
melanoma, malignant
memory, impairment of
meningeal biopsy
meningeal enhancement
meningitis
meningitis, aseptic
meningitis, bacterial
meningitis, granulomatous
meningitis, TB
menses
menses, irregular
metallic taste
methotrexate
mimics
misdiagnosis
mitoxantrone
modafinil
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, black holes on
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength, high
MRI, hypointense signal foci on
MRI, lesion burden
MRI, magnetization transfer sequence
MRI, negative
MRI, optic nerve
MRI, ring sign, open
MRI, serial
MRI, volumetry
MRS
multinucleated giant cell
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, aggressive
multiple sclerosis, asymptomatic
multiple sclerosis, benign form of
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, diet in
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, disease activity
multiple sclerosis, early onset
multiple sclerosis, epidemiology of
multiple sclerosis, etiology of
multiple sclerosis, lesion location
multiple sclerosis, linoleic acid in
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pain in
multiple sclerosis, paroxysmal symptoms in
multiple sclerosis, pathogenesis
multiple sclerosis, plaque
multiple sclerosis, preclinical
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
multiple sclerosis, tumefactive
multiple sclerosis, worsening
muscle atrophy, static
muscle pain
muscle stiffness
muscle weakness
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
mycophenolate
myelin basic protein
myocardial injury
myocytolysis
myokymia
N-acetyl-L-aspartic acid
natalizumab
natalizumab, discontinuation
nausea and vomiting
negative
neurofilament light chain protein
neurogenic bladder
neurologic complications
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic examination
neurologic practice
neurologic signs
neurologic symptoms
neurologist
neuromyelitis optica (Devic's disease)
neuromyotonia
neuropathology
neuropathology, brain
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, multifocal
neuropathy, peripheral
neuropathy, peripheral, treatment
neuroprotective agents
neurosyphilis
neurotoxic
neurotoxin
neutralizing antibodies
neutropenia
nevus
nocardiosis
nocturia
nonsteroidal anti-inflammatory drug
ocrelizumab
ofatumumab
opportunistic infection
opportunistic infection, CNS
optic neuritis
optic neuritis, treatment of
optical coherence tomography
organ transplantation
outcome research
oxybutynin
pachymeningitis, cranial
pain
pain, abdominal
pancreatitis
pancytopenia
paraparesis, spastic
paresthesias
Parkinson disease
Parkinson disease, L-dopa nonresponsive
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
paroxysmal neurologic deficits
patient information and support
pemoline
pentoxifylline
pericarditis
personality change
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
pleurisy
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
postpartum
practice guidelines
precipitating factors
pregnancy, neurologic complications in
prevention of neurologic disorders
primrose oil
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
radiation therapy, CNS treatment and complications with
radiation therapy, total body
radiculopathy
Ramsay Hunt syndrome
rash
rebound
ReBUILD study
recurrent
remyelination
renal failure
research
retinopathy
reversible neurologic disorder
review article
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sedimentation rate, elevated
seizure
serologic testing
seropositive
serum alanine aminotransferase
serum glutamic oxaloacetic transaminase
shared decision making
simvastatin
sinemet
skin, lesions in neurologic disorders
spasticity
spasticity, treatment of
spinal cord, injury of
spinal cord, injury, management of
statin therapy
stem cell transplantation
stereotaxic surgery
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
stimulation, deep brain
subspecialist
sweating
sweating, abnormality of
syphilis, neurologic complications with
T cell lymphocytes
tentorium cerebelli
teriflunomide
thalamotomy
thrombocytopenia
tizanidine
tolebrutinib
tolerance
treatment of neurologic disorder
tremor
tremor, cerebellar
tremor, surgical treatment of
tremor, thalamic stimulation for suppression of
tremor, treatment of
tricyclic antidepressant
tuberculin skin test, positive
tumor necrosis factor
tumor necrosis factor inhibitor
urinary retention
urinary tract infection
urodynamics
vaccination, neurologic complications with
vaccine
valium
vasopressin
ventricular enlargement
vertigo
vertigo, cervical
vertigo, treatment of
viral infection
viral infection, CNS
viral infection, reactivation
visual acuity
visual acuity, decreased
visual evoked response
visual loss
vitamin D
vitamin supplementation
vitamin, multiple
weakness
web sites
white matter disease
workup
yoga
Showing articles 950 to 1000 of 4044 << Previous Next >>

Trauma Does Not Precipitate Multiple Sclerosis
Arch Neurol 57:1077-1078, Cook.S.D., 2000

Pathologic Damage in MS Assessed by Diffusion-Weighted and Magnetization Transfer MRI
Neurol 54:1139-1144, Cercignani,M.,et al, 2000

Progressive Cerebral Atrophy in MS
Neurol 54:807-812,782, Fox,N.C.,et al, 2000

Total Brain N-Acetylaspartate, A New Measure of Disease Load in MS
Neurol 54:15-19, Gonen,O.,et al, 2000

Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000

Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000

Glossopharyngeal Neuralgia and MS
Neurol 54:1368-1370, Minagar,S.&Sheremata,W.A., 2000

Primary Neurosarcoidosis:A Diagnostic and Therapeutic Challenge
The Neurologist 6:126-133, Nikhar,N.K.,et al, 2000

Outcome of Surgery for Thoracic Outlet Syndrome in Washington State Workers' Compensation
Neurol 54:1252-1257, Franklin,G.M.,et al, 2000

Multiple Sclerosis and Antecedent Infections
Neurol 54:2307-2310, Marrie,R.A.,et al, 2000

Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000

Heterogeneity ofMultiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination
Ann Neurol 47:707-717, Lucchinetti,C.,et al, 2000

Open-Ring Imaging Sign
Neurol 54:1427-1433, Masdeu,J.C.,et al, 2000

Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000

De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000

Reduced Signal Intensity of T2 Weighted MR Imaging of Thalamus and Putamen in Multiple Sclerosis in Japan
Rinsho Shinkeigaku 40:677-682, Nishii,T.,et al, 2000

Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999

Multiple Sclerosis Associated with Uveitis in Two Large Clinic-Based Series
Neurol 52:179-181, Biousse,V.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Trigeminal Neuralgia Triggered by Auditory Stimuli in Multiple Sclerosis
Arch Neurol 56:731-733, Hartmann,M.,et al, 1999

Fibromyalgia Syndrome a Decade Later
Arch Int Med 159:777-785, Goldenberg,D.L., 1999

Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999

Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999

Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR 20:813-820, Rovaris,M.,et al, 1999

Quantitative MRI in CADASIL, Correlation with Disability and Cognitive Performance
Neurol 52:1361-1367, Dichgans,M.,et al, 1999

Magnetization Transfer Imaging of Patients with Definite MS and Negative Conventional MRI
Neurol 52:845-848, Filippi,M.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis,Relation to Inflammatory Activity
Arch Neurol 56:345-351, van Walderveen,M.A.A.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999

Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999

The Relationship of MS to Physical Trauma and Psychological Stress, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1737-1745, Goodin,D.S.,et al, 1999

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Cavernous Haemangioma Mimicking Multiple Sclerosis
BMJ 318:1604-1605, Cader,M.Z.&Winer,J.B., 1999

Cerebrospinal Fluid Findings in CADASIL
Neurol 53:233, Dichgans,M.,et al, 1999



Showing articles 950 to 1000 of 4044 << Previous Next >>